Prognosis of patients with ventricular tachycardia and ventricular fibrillation: Role of the underlying etiology  by Trappe, Hans-Joachim et al.
Prognosis of Patients With Ventricular Tachycardia and Ventricular 
Fibrillation: Role of the Underlying Etiology 
HANSJOACHIM TRAPPE. MD, PEDRO BRUGADA, MD, MARIO TALA;IC, MD, 
PAOLO DELLA BELLA, MD, ROMAN LEZAUN. MD, ROB MULLENEERS, BA. 
HEIN I. I. WELLENS, MD, FACC 
The prwmsis of I49 patients wilh ventricular tarhywdia 
t” = 106) “r ventricular Bbrillati”” (n = 41) was analyzed 
b 8ssess the b”p”*ncc OF the underlying etiotogy OF the 
orrbytbmio. Seventy-three patients Woup I) bad a previ- 
ous myocardld Infarctlo” and docume”tod late sustained 
monamnrphlc ventricular lachycardla. ThirlyAve Graup 
II, ~1s” had a lwious mywrdlal tnfsrctton but hnd late 
vcntrtculor ttbritlatio”. There were 41 patients (Group III) 
wlthout roronrwy artery disease: 9 patiez&s with right 
ventricular dysplasia, 26 with idiopathic rurtstned veotrte. 
ulsr tachywdia and 6 with idiopathic ventricular fibrtlla. 
tim. The mea” follow~up pried for all patients was 22 to 
57 rn”“‘bS. 
The total mortality rate in t&up I(t68) and Group II 
(34%) and the srrbytblnic m”rM‘y ra‘e in Croup I (5%) 
and Group II (,I%, sereslgtRco”Uy htgber ‘ha” the ra‘es 
in Croup 111. I” thelattergroupthe total mortality rate was 
4% f”r tbwe wilb idiupatbic ventricular tachyrardia and 
11% for thae with right ventricular dysplasia, and there 
were no deaths due to arrhvthmia TV < 0.09. Letl vm. 
trirular ejectinn fractinn &s sipifirantly lower and Ml 
~entrieular eddinslolic prr~ure wss sigtdkantly bi@er 
in Group I and Group II tbn” in Group 111. Tbwe were 
nonfatal reewreneos of ventrlctdar tarhycardia in 33 la 
56% of patients, and Ihe number of thw episodes did not 
differ Significantly in those with and witbwt cornnary 
artery likeare. 
I” s”mmary, althaugh ‘be incidence of rwurre”ce of 
nonfatal ventrteular lachvenrdia is slmilnr in ontients with 
and without mronsry art& dkwl tmal rmd arrhythmte 
martality is signtticantly higher in p.lie”ts with carenary 
arterv disease and is related to the deemaf left veMcular 
dyslunction. The prwwsis of pa& with right ventrbm 
bar dysplasia, idiopathic vmtrieular tachycardis “r vat. 
triruk; fibrillation; is ereollent whol th& pstienb are 
treated medk:!;. 
fJ ~!?.m Ce!l Car&of *988;12:166-74) 
The nvajorny ofpmicnts with sustained vemricularschycar- 
die or ~~entriculnr fibrillation have underlying coronary sr- 
fery dlacase and previuur myocardial infarction (l-5). How- 
ever. recurrent episodes of sustained ventricular tachycardia 
or vcnlricul”r fibrillation are alao found in patients with 
struclur”l heart diszase due to cwbes other than coronary 
artery dircase or even in patients without identifiable heart 
disesse &I?l. The purpoac of this study was to assess the 
imponancc of Ihe underlying etiology of ventricular lachy- 
cardia or ventricular fibrillation in relotion to mortality and 
the recurrence of the arrhythmia. 
Methods 
Study patients. One hundred forty-nine consecutive pa 
ticnts were studied. All had electmcardiographicaIly (ECG) 
documented episodes of spontaneous recurrent sustained 
ventricular tschycardia (n = 108) or ventricular fibrillation t” 
= 41). There &.re 73 :s!ie!?!s !Grcop I) with ? previous 
myocardial infarction and sustained monomorphic vemricu- 
Iw tnchycardia (duration >30 9. and 35 patients tGroup II) 
with a previous myocardial infarclion and ventricular Rbril- 
lation (Tables I and 2). There were 41 patients (Group 111) 
withoul coronary artery disease: Y had arrhythmogenic right 
venlricular dysplasia and 37 bad no structural heart disease 
(“idiopathic” ventricular arrhythmies). Sustained mooo- 
morphic ventricular tnchycardia was Ihe arrhythmi- ;” all 
patients with right ventricular dysplasia and in 26 of Ihe 
patiems without structural heart disease. Ventricular tihril- 
letion occurred in the remaining six patients (Tabie 3). 
yauents receiving anti&rhythmic &gr. The rtmw:anon 
prolocol iomilled of I, 2 or 3 right apical ventricular 
premature beal\ given at twice the diastolic thresiwld dunng 
hmos rhythm and during pacing I the right ventricular apex 
at K&I of IOU. I20 ar,d 140 be&min. The end point oithe 
\timu!ation protocol was the induction of the clinically 
documentrd ventricular arrhythmia (13). 
Trentm~t. Among the 108 patients with coronary snery 
d&w. amiodaronc was the mosl commonly given drug (46 
par~enls. 4J”cl: class I antiarrhythmic drugs &re gven Lo 27 
wticots (?5%l m the CIOUD. Patients with rich1 ventricular 
dysplasia received a&&one (I patient). a;las I drug (2 
patients). aotalul 12 p&W and enczainidc (2 patients). 
Patients without structural hean disease were treated with 
ammdarone (I? patents; or rotalot (6 patients): and and- 
orrhythmic lw I drugs were given less frequently (Tehle 4). 
During the followup period. five patients (7%) with 
myocardiill mbrction and ventricalar tachycardia underwent 
aortocoronary bypass gafting and four patleots (6%) had 
aneuryrmeclomy with endocxdial resection. Among pa- 
wn!: s:!? ?yecarddia! infarciion and ventriculnr Bbriil;:i;a. 
three (9%) had aortocoronary bypass grafting and Iwo (6%) 
underwent aneurysmectomy. one having addilional endocar- 
dial resection. One patient with righl ventricular dysplasia 
underwent surgery (right venwicular disconnection) and died 
postoperatively from heart failure. Among pittienls wilt. 
idiopathic ventricular tachycardia. an anlitachycardis pace- 
maker WQS implanted in three patients (12%) and endxardial 
resection wa performed in one patient (3.8%!. One patient 
with idiopathic ventricular fibrillation and recurrent episodes 
of ventriculx fibrillation reccivcd an automatic implantable 
defibrillator. 
Magwatk studies. All patients underwent a detailed his- 
top’ and physical examination. a I2 lead ECC. laboratory 
analysis and a chest X ray film. M-mode and two- 
dimensional echocardiography were carried out in 76 (70~8 
of the KM patients with coronary nnery disease and in all 
patients without stro:turaI hean disease. 
Coronury anpiogruphy und IeJt ~,unrri~~~l,~~r~tpi~y were 
performed wilh the Iudkins technique itI all patients with 
coronary artery disease and in 38 (93%1 of 41 patiemb wilh 
right ventricular dysplasia or idiopathic ventricular arrhylh- 
miss. All patients with right vcnlricular dysplasia had both 
left and right ventriculography. 
is en~yfow how lon.e-le-rrrm ECG monirorin~ was pcr- 
formed before angiography in all patieols. One hundrad 
seven patieots were studied using a treadmill. according 10 
the Bruce protocol. Exercise tests were symptom-limited. 
Proyrmnnwd elrrtricnl slimelorion OJ rhr hrnrr was per- 
Fdlow-up. All parients were seen in the outpatient clinic 
a, leaat once a year. The meen follow-up periods of the 
different groups are listed in Tables I and 2. All cases of 
death were verified and classified by interviews with rela 
lives. family or hospital physicians and. if possible. by 
awalyring hospital charts. Sudden death in this patient pop 
ulation was defined as witwssed death occurring by rl h of 
the onset of svmotoms. 
Statirtiral bn&sls. Statistical analysis was performed 
using the paired and unpaired Student’s r lest and the 
chi-square tert. Survival wrves were analyzed using life- 
tilhle analyris. P values <il.175 were considered significant. 
Results 
T&l mortality and in&knee alsudden death. During the 
follow-up period of39 months. 26 (17%) of Ihe 149 patients 
died, 8 (5%) shddenly. Among the 73 patients with a previ- 
ous myocardial infarction and ventricular tachycardia 
(Group I). 12 (16%) died, 4 suddenly, 4 from recurrent 
myocardial infation. 3 frum congestive heart failure and I 
from suicide. Among the 35 patients with a previous mvo- 
cardial infarction and ventricular fibrillation &wp ll).~lZ 
(34%) died, 4 suddenlv. 3 from recurrent mvocardial infarc- 
tion, 3 from congesti& heart fadure, I hi a stroke and I 
from suicide. Of the 41 Group 111 patients, no patient died 
suddenly and one patient died from low cardiac output after 
surgery. Among patients without structural heart disease, no 
patw~t died suddenly, and one died from lung cancer. 
Teal mormliry was significantly higher in patients with 
corowry artery disease (24 l29%] of 108) than in those 
without left ventr~ular diseasc (2 15%1 of 41) (I) < 0.021. In 
addition, cardiac mortality was higher in pet&s with COT- 
ooar) artery disease and ventricular fibrillation (IO [2Y%] of 
351 than it was in patients with coronary artery disease end 
ventricular tachycardia (I I Ll5%1 of 73) (p = 0.08) (Fig. 1). 
No sianiticanl difFsrences were found between the incidence 
of sodden death in patients with coronwy artery disease and 
that :n patients with ventricular tachycardia (Group I) (4 
[6%1 of 73) or ventricular fibrillation (Group II) (4 [I I%] of 
35) (Fig. 2). 
Previous clinical cbaraeterisU*l. All patients with con- 
nary artery disease had a history of myocardial infarction 
and showed typical ECG signs (Q waves). Among the 73 
palienls with sustained monomorphic vewicular tachycar- 
dia (Group l), the prior irdarction was anterior in 31 (43%). 
inferior in 35 (48%) and both anterior and inferior in 7 (IO%): 
among the 35 padents with ventricular fibrillation (Group 11). 
the prior infarction was anterior in 20 (57%), inferior in 4 
(I I%) and both anterior and inferior in I I (31%) (Table I). 
Tfw inrervul bctwee~I tnyorardial ir&rr/ion and vmrriru- 
br kwf~yycrrrdiu was z-6 months in 40 patients (56%). 
whereas it was <Z months in most (63%) of the 35 patients 
with ventricular librillation. 
Fwwionol rbss. Of the 73 Group I patients with a 
previous myocsrdial inlxction and ventricular tachvcardia. 
57 (74%) were classified in the New York Heart A&iation 
functional class 1. I5 (21%) in class II and 4 (6%) in class III. 
In contrast. among the 35 patients with a prior infar xion and 
ventricular fibrillation Group II). 12 (34%) were clarsiiied m 
functional class 1. 9 (26%) in class II and I4 (40%) in clw 
III. 
Most of the parienrs wlro did were in functional class II 
or III (Group I: 6 of I I padenrs, 55%: Group II p*tirnla: 7 of 
9 patients. 78%) (p = na). All padenlr whh no coronary 
artery disease (Group 1111 had functional class I heart hdure 
(Table 3). 
LcN venlricular funclion and wonary angiography. Sig- 
nificant differences were found between degree of kft ven- 
tricular dysfunction in padents with and without coronary 
ancry disease (Tables I lo 31. Left vcnoicular ejecdou 
fraction was significantly higher and left ventricular end. 
diastolic pressure was significanlly lower in patients wilboul 
coronary ancry disease (Group Ill) Ip < 0.051. Ejection 
fraction and left ventricular end-diastolic pressure did not 
differ significantly in patients with myocardial inforcdon who 
died suddenly and patients who died from a cardiac crux or 
in patients who died suddenI\ and survivors ITable 2). 
However. there wns a trend toward a lower eiec!ion fncdon 
and a higher left venlricular end-diastolic ~rcssurc in pa- 
uentr who dird sudden+ (mean ejection fraction 35 2 7%. 
rn~~n end-diastolic pressure ?I 2 17 mm Hp) compared with 
values in wivivors lmean ejection fraction 35 + I2%, mean 
end-diaslolic pressure 17 ? Y mm Hg). Three vessel core- 
nary artery disease was significantly (p < 0.01) mare prev- 
blent in the group with ventricular fibrillation (22 patients 
71%) lhan in the group with ventricular tachycardia (25 
oaucntn. 39%). In addition. 3 oalients (10%) with ventricular 
khrillation had only one &I disease compared with 20 
patienls (31%) with ventricular mchycardia Ip i f1.05). 
Rlien~s who died had a greater number ofcoronnry arteries 
involved than did survivors (Table 2). 
Long-term c~tnwxdiiphic monitoring. There were 
no +gificanr differcwx hrtwew :br ;a;lJxce of isolated 
prcmawrc ventricular beats (Low class I to 3) or 
“compler” ventricular arrhythmias (Lown class 4 and 5) in 
patients with myocardial infarction and venlricular tachycar. 
dia or fibrillation and that in oalientr withoul coronary arterv 
disease. However. the incidence of complex arrh$hmiai 
we >Stt% in all groups. 
AnzArlrrfor.v ECG wrordirlgs during mliarrhyrhndc drug 
lreolrnenl showed a 60% incidence rate of class I to 3 xnd a 
40% incidence rate of class 4 arrhythmia in patients with 
myocardial infxclion and venlricular tachycardia or ven- 
tricular fibrillation. The incidence rate of class I lo 3 arrhyth. 
mia was 30% and that of class 4 arrhythmia WK. 60% in 
patients without coronary artery disease (Table 5). 
Programmed stimulation in absence of antiarrhythmic 
drugs (Table 6). Sustained monomorphic ventricular tschy- 
czrdia was induced in 35 (83%) of 42 patient% with coronary 
artery disease and spontaneous ventricular ttachycardia 
(Group 1). In live Group I patients II?_%) nonsustained 
ventricular tachycardia was inducible and in the remaining 
two patients (5%) no arrhythmias wcrti inducible. In patients 
with spontaneous ventricular fib-illation (Group II). ventric- 
ular fibrillation was induced in 6 (32%) of 19 patients. and 
sustained monomorphi,: ventr~culdr lachycardia in IO (53%): 
in the remaining 3 paticnfs (16%) no or only nonsustained 
ventricular tachycardia was induced. 
During rl~ewoplzysiologic smdy in Group 111. sustained 
ventricular tachycardia was induced in all patients with right 
ventricular dysplasia. In contrast. among 21 patients with 
idiopathic ventricular tachycardia, sustained ventricular 
tachycardia was induced in 9 (43%) and no or nonsustained 
ventricular tachycardia was observed in I2 (57%). In four 
patients with id&athic ventricular tibrillrdion programmed 
stimulation was performed; sustained monomorphic ventric- 
ular tachycardia was induced in two patients and ventricular 
fibrillation in the remaining two. 
The mode of iniriurion of vmtricrdm arrhythmias was not 
significantly different in patients with and without myocardial 
infarction. In the majority of patients, two ventricular ex- 
trastimuli were required to induce the arrhythmia (Table 6). 
Programmed stimulation during anliurhy(hmic drug 
treatment (Table 2). .‘mong 50 patients with myocardial 
infarction and ventricular tachycardia (Group I). sustained 
monomorphic ventricular tachycardia was inducible in 40 
NJ%), ventricular fibrillation in I (2%) and nonsustained 
ventricular tachycardia in 5 (10%); no arrhythmias were 
induced in 4 patients (8%). Among 28 patients with mywar- 
dial infarclion and initial ventricular fibrillation (Group II). 
ventricular fibrillation was induced in none. sustained mono- 
morphic ventricular txhycardia in 12 (0%) and non- 
sustained ventricular tachycardia in 2 (7%): no arrhythmias 
were induced in 8 patients (2%). 
Table 5. lncidcncc ofSpz!aneuus Ventricular Arrhythmias Daected by 24 h Long-term KG Rccordingr 
CA” SIVT,%I CdD YF ,%I RYD ,!a ld,o SMVT IS, 
I” = 73, ,n = 35, ,n = 9, ,n = tf., 
A. Whoul antlarrhylhmic uwnmt 
Number of pa,,cn,\ 47 WI 17 ,491 6,67) 17 (65, 
Low” Cl*\* 
dinin. sustained monomorphic ventricular tachycardiu wax 
still inducible in 3 oatients l?7%1. ventncular fibnllation in I 
patient (9%) and nonsustained vcnfricubu tachycardra m 2 
patients (18%): no arrhythmias were induced m 5 patients 
(46%). Electraphysiologic study with the patient, recewing 
drugs was performed on four patients with spontaneow 
idiopathic ventricular fibrillation: vcnfricular fibrillaion ww 
induced in one patient. sustained monomorphic ventricular 
tachycardia in one. nonrur&cd ventriculx tachycardia in 
one and no arrhythmias in one. 
Tk wde of inilirrrwt did not dilfer signifxantly m 
patients with and sithout myocardinl infarction. In the 
majority of patients. two ventricular extlilstimtdi were re- 
quired to induce the arrhythmia. 
Ventricular tachycardia cycle lenwh. The cycle length of 
the clinical documented venlricular lachvcardi and the 
induced sustained ventricular tachycardia before or during 
;mti:arhythmlc drug treatment showed no signific;mt dilfer- 
MC:\ bstwen patients wth and without coronary artery 
d~ww tT;iblcs 6 and 71. Howcvcr, both the cycle length of 
the clintcal wnbicuktr rachycardla and the induced vcmric- 
ulx tachvcardia in the absence of druzs wre shorter in 
patient* wth right ventriculn: dysplasia compared wth the 
other patient\. No slgnificnnr dilTerences were found in the 
cycle length of induced ventricular rachycardia in p;ltients 
nho were or were not receiving nnriwrhythmic drug treat- 
ment. 
Recurrences of ventricular tachymrdio. Recurrences of 
do rhylhnuc events were fatal only in p&enls with coronary 
artcry dkeax (Groups I and II). Four patients (6%) with 
spontaneow sustained mommorphic ventricular tachycar- 
dia died uddenly. as did four patients (I 1%) with docu- 
mented \pontnneous ventricular fibrillation. 
T!;r br~hluwc vf mm$tnl ordNhic evt~~r~ Ilnri,zg rlrc 
Jdlowrp did not differ in patients with and without prsvious 
myocardial inhrction. Nonfarsl orrhythmic events occurred 
in 19 patients (26%) in Group I fprior infarction and ven- 
triculur txhycardia) and in 2 piltients (6%) in Grcup II (prior 
infarction and ventricular fibrdlationl. The incidence of 
nonfatal arrhythmic events was hxginer no patients with 
noncoronary artery disease Group III). Five patients (56%) 
with right vcmricular dysplasia. 10 patients (39%1 with 
idiopathic vrntrudar tachycardia and 2 patients (3311 with 
idiopathic wn~rirukw tibrillation had recurrent nanLlal ven- 
tricular t&ycardia. 
Antinrrhythmic drug treatment and clinical wtcome. 
Four pzatients m Group I (prior inlarction and spontaneous 
sustained ventrular tachycardia) had a fatal arrhythmic 
event. Two of them were receiving amiodarone 1200 mglday 
and 400 m&p. rcspectivelyl at the time of sudden death; 
the remaining two patients were treated with bepridil (400 
mgldayl. Whether a proarrhythmic effect was the cduse of 
sudden death is unknown to US. 
1,~ G‘ror~p I/ (prim infur~~i0r~ and bziriul wsrri< durfihril- 
Idlion), four patient5 died suddenly. At the time of death, 
two pauems were receiving amiodarone (400 mpldayt, one 
patient was receiving Rccainide l2W mgldayl and one was 
receiving procdinamide (3.000 mglrlay). 
Nw~f~~fol ~~pkxk.x OJ vrrmkwlrw rorkgwwdb rmwwd in 
49 poricrrr~ 129$/J. in the majority during treatment with a 
class I antiarrhythmic drug. Approximately 40% of the 
patients in Groups I and II with recurrent ventricular tachy- 
cardia were receiving smiodarone. compared with 20% of 
patienls in Goup 111 with rccurrcnt vcnu’icular tachycardta. 
Discussion 
Identification of patients at high risk for sudden death 
remain, a difficult problem. It has been reported that the 
etiology of ventricular tachycardia is an important consider- 
ation in treatment end prognosis (14). Therefore, we evalu- 
ated the incidence of sudden death in relation to the under- 
lying heart disease. 
Prognosis in patients cithout eorcmary artery disease. 
There is general agreement that patients with sustained 
ventricolu tachycardia unrelated to coronary artery disease 
have a belter prognosis than do patients with ventricular 
tncbyadid after myocardial infarction (ISI. In our series of 
26 patients with sustained vemricular twhycardia without 
~trucl~~nd heart dircasc. no patient died suddenly during a 
mean follow-up period of 47 months. In addition. no sudden 
death occurred .in patients with “idiopathic” ventricular 
fibrillation. Thcsc data arc in agreement with previous 
atudics dcmonstratinr an excellent ooxr&s in such DB- 
Gents (16-191. Mowc;er. there are some reports of sudden 
death in patients with idiopathic ventricular tachycardia 
lM22). 
Prognosis in patients with coronary artery disease. The 
incidence of sudden death is much higher in pauents with 
coronary artery disease (23-B). particularly in patients 
having oath poor left veotrular function and rc~idual 
ischemia (26,27). The prognosis of paienls with coronary 
artery disease is clearly inAucnced by the presence of 
ventricular arrhythmias ,281. Risk stratification in these 
groups of patients 8s essential for treatment and prognosis. In 
this study. the total mortality rate in patients with coroaary 
artery disease and spontaneous ventricular tachycardis or 
ventricular fibrillation was 16.4% and 34.3%. respectively. 
These data are in agreement with those of other invesrigalms 
(29-31,. 
Role of left ventrieutar dysfunction. Total mortality and 
incidence of sudden death were clearly related to the degree 
of left ventricular dysfunction. Left ventricular damage was 
more extensive in patients who died during the follow-up 
period than in survivors. The number of involved coronary 
artertes. left ventricular ejection fraction and clinical data 
(exercise test. functional class) differed markedly in patients 
with and without coronary artery disease. In addition, both 
clinical and angiographic and hemodynamic findings were 
signiiicantly different in patients with and those without 
coronary artery disease. 
Role of ambulatory ECG monitoring and programmed 
stimulation. Therefore, to evaluate the risk of sudden death, 
clinical information about the underlying heart disease, 
noninvasive or invasive studies. or both, are required. 
Long-term ambulatory ECG monitoring is a widely accepted 
method, in the diagnostic evaluation of ventricular arrhyth- 
mias, to determine the frequency and severity of ventricular 
ectopic rhythm (32). In our study it WIE not possible to 
stratify the risk of R patient to develop malignant arrhyth- 
mias using these criteria alone. Classification of a patient at 
hxgh risk for sudden death was not possible on the basis of 
programmed stimulation alone. a finding in agreement with 
other repons (4.33-40). 
Role of anliarrhythmic drug therapy. In pdtienls with and 
without coronarv arterv disease. the incidence of nonfatal 
arrhythmic eve& during antiarrhythmic drug treatment did 
not differ significantly and did not allow for a risk stratifica- 
tion. Although antiarrhythmic drug treatment frequently 
could not prevent recurrent ventricular tachycardia. a recur- 
rent arrhythmia was rarely associated with sudden death in 
all groups. 
Limitations. Our patients with idiopathic ventricular 
tnchycardia did not undergo cndomyocardial biopsy: thcre- 
fore. myocarditis. as reported by Vignola et al. (41). was not 
completely excluded. We had no clinical reason to suspect 
myocarditis in any patient classified as having “idiopathic” 
ventricular txhycardia. As reported by Vignols et al. (42). 
however, clinically silent lymphocytic myocarditis could 
have been responsible for ventricular lachycardia in some of 
our patients. Also, data from programmed stimulation and 
long-term ECG monitoring were not available for all pa- 
tients. Conclusions in terms of predicting recurrences of 
tachycardias apply only to patients for whom data were 
available. 
Clilieal impHcations. The risk uf wddm death in pntients 
with wstamed monomorphic venlricular lachycardia UT ven- 
tricular fibrillation is clearly related to the underlying hart 
disease. Qarlicukdy to the degree of lefl ventricular dysfunc- 
tion. Patients without structural hear! direase or Ibow with 
right ventricular dysplasia have an excellent prognosis when 
treated medically. despite recurrences of ventricular tacby- 
cardia. Prognosis. however. may differ in panems wb~sc 
ventricular tachycardia is associated with types of hart 
disease. cardiomyopathy for example. other than those 
included in this study. 
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